Efficacy of Extracorporeal Magnetic Stimulation, Pelvic Floor Muscle Exercise, and Combination of Both in Management of Post Radical Prostatectomy Urinary Incontinence

NCT ID: NCT05680168

Last Updated: 2023-01-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-01

Study Completion Date

2029-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Urinary incontinence is one of the most common complications of radical prostatectomy. Multiple prevention and treatment modalities have been proposed in the management of post prostatectomy urinary incontinence. This is a randomized controlled comparative study to evaluate the efficacy of extracorporeal magnetic stimulation alone and combined with pelvic floor muscle exercise versus pelvic floor muscle exercise alone in the management of post radical prostatectomy urinary incontinence. This study is expected to be performed over 7 years. The study population will be all male patients who are prepared for radical prostatectomy under urology department in HMC and were referred to voiding dysfunction for preoperative counselling and postoperative rehabilitation. Patients will be randomized into one of three treatment groups. The first group will receive sessions of extracorporeal magnetic field stimulation only. The second group will receive extracorporeal magnetic stimulation in addition to pelvic floor muscle exercise. The third group will receive pelvic floor muscle exercise only. The recruitment phase will take 3 years. Patients will be followed for 18 months for the course of urinary incontinence symptoms, severity of urinary incontinence on 1-hour pad test, urodynamic leak point pressure and the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF) and the ICIQ quality of life (QOL) score. This study is proposed to reveal strong evidence on the efficacy of extracorporeal magnetic stimulation on the management of post radical prostatectomy urinary incontinence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post Radical Prostatectomy Urinary Incontinence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A: Extracorporeal Magnetic stimulation

Group (A): will receive rehabilitation program with exposure to ExMS, Patients will receive regular sessions of electromagnetic stimulation using Magneto STYM device, (Iskra medical d.o.o, Slovenia). Each session will last for 20 minutes. Patients will receive three weekly sessions for total of 20 sessions starting one month after catheter removal.

Group Type ACTIVE_COMPARATOR

Extracorporeal electromagnetic stimulation

Intervention Type DEVICE

Electromagnetic stimulation using Magneto STYM device, (Iskra medical d.o.o, Slovenia).

Group B: Extracorporeal Magnetic stimulation and pelvic floor exercises

Group (B): This group will receive a rehabilitation program depending ExMS with the protocol described above. In addition, this group will be advised for pelvic floor muscle training in serial training sessions with our therapist for PME.

Group Type ACTIVE_COMPARATOR

Extracorporeal electromagnetic stimulation

Intervention Type DEVICE

Electromagnetic stimulation using Magneto STYM device, (Iskra medical d.o.o, Slovenia).

Pelvic floor exercises

Intervention Type BEHAVIORAL

Pelvic floor muscle training in serial training sessions with our therapist

Group C: Pelvic floor exercises

Group (C): This will be the control group. This group will be advised to do PME only. The pelvic floor exercises will consist of advice to the patients to contract the anal sphincter muscles in successive way as if holding flatus. The pelvic floor muscle training schedule and therapist in group B and group C will be the same.

Group Type ACTIVE_COMPARATOR

Pelvic floor exercises

Intervention Type BEHAVIORAL

Pelvic floor muscle training in serial training sessions with our therapist

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Extracorporeal electromagnetic stimulation

Electromagnetic stimulation using Magneto STYM device, (Iskra medical d.o.o, Slovenia).

Intervention Type DEVICE

Pelvic floor exercises

Pelvic floor muscle training in serial training sessions with our therapist

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The study population will include all adult male patients 18 years of age and above, with localized prostate cancer of low or intermediate risk disease who chose definitive treatment with radical prostatectomy either through open radical retropubic prostatectomy (RRP) or through robotic assissted laparoscopic radical prostatectomy (RALP) as first line for treatment and had the surgery under Hamad General Hospital urology department care.

Exclusion Criteria

* Patients with high risk , locally advanced or metastatic prostate cancer at time of diagnosis
* Patients with low to intermediate risk prostate cancer who received chemo or radiotherapy then had salvage surgery
* Patients with urinary incontinence or diagnosed overactive bladder before radical prostatectomy.
* Patients with complicated surgery resulting in anastomotic leak, prolonged catheterisation more than 3 weeks, reinsertion of catheter due to retention of urine.
* Patients who refuse to participate in the clinical trial.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hamad General Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed Albakr

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ambulatory Care Center

Doha, , Qatar

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Qatar

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ahmed Albakr

Role: CONTACT

33757500 ext. 974

Ardalan Ghafouri

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ahmed Albakr

Role: primary

33757500 ext. 00974

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MRC0122185

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Physical Therapy for Men Undergoing Prostatectomy
NCT02558946 ACTIVE_NOT_RECRUITING NA